Cargando…

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects

BACKGROUND: This study aimed to evaluate the effect of travoprost with sofZia® preservative system for lowering the intraocular pressure (IOP) of Japanese normal tension glaucoma (NTG) patients. METHODS: In this prospective, multicenter, open-label study, Japanese NTG patients with baseline IOPs <...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizoue, Shiro, Nakano, Tadashi, Fuse, Nobuo, Iwase, Aiko, Matsumoto, Shun, Yoshikawa, Keiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917943/ https://www.ncbi.nlm.nih.gov/pubmed/24520191 http://dx.doi.org/10.2147/OPTH.S57640

Ejemplares similares

Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system
por: Ryan, Gerard, et al.
Publicado: (2011)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study
por: Nakano, Tadashi, et al.
Publicado: (2015)

Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma
por: Naito, Tomoko, et al.
Publicado: (2016)

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Nomura, Yuya, et al.
Publicado: (2010)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold, Leonard K, et al.
Publicado: (2014)

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma
por: Igarashi, Ryoko, et al.
Publicado: (2014)

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2012)

Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
por: Naito, Tomoko, et al.
Publicado: (2015)

Efficacy of travoprost for the treatment of patients with glaucoma
por: Zhang, Xiu-Li, et al.
Publicado: (2019)

Results of the AcrySof Toric intraocular lenses implantation
por: Œwiątek, Bożena, et al.
Publicado: (2012)

AcrySof toric intraocular lens for post-keratoplasty astigmatism
por: Gupta, Nishant, et al.
Publicado: (2012)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
por: Yoshikawa, Keiji, et al.
Publicado: (2021)

Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
por: Quaranta, Luciano, et al.
Publicado: (2015)

Travoprost in the management of open-angle glaucoma and ocular hypertension
por: Denis, Philippe, et al.
Publicado: (2007)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2012)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events
por: Tsumura, Toyoaki, et al.
Publicado: (2012)

Contrast Sensitivity and Spherical Aberration in Eyes Implanted with AcrySof IQ and AcrySof Natural Intraocular Lens: the Results of a Meta-Analysis
por: Liu, Jianping, et al.
Publicado: (2013)

Travoprost Liquid Nanocrystals: An Innovative Armamentarium for Effective Glaucoma Therapy
por: El-Gendy, Mohamed A., et al.
Publicado: (2023)

Monte Carlo simulation of expected outcomes with the AcrySof(® )toric intraocular lens
por: Hill, Warren, et al.
Publicado: (2008)

Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model
por: Yoshikawa, Keiji, et al.
Publicado: (2018)

Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
por: Lopes, Joao F., et al.
Publicado: (2015)

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
por: Dubiner, Harvey B, et al.
Publicado: (2012)

First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado, Ahmed Salah, et al.
Publicado: (2012)

Is intraocular pressure reduction the key treatment for normal-tension glaucoma?
por: Chen, Mei-Ju
Publicado: (2020)

Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)
por: Kim, Joon-Mo, et al.
Publicado: (2021)

AcrySof IQ PanOptix Intraocular Lens Versus Extended Depth of Focus Intraocular Lens and Trifocal Intraocular Lens: A Clinical Overview
por: Sudhir, Rachapalle Reddi, et al.
Publicado: (2019)

Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
por: Perera, Shamira A, et al.
Publicado: (2016)

Intraocular asymmetry of visual field defects in primary angle-closure glaucoma, high-tension glaucoma, and normal-tension glaucoma in a Chinese population
por: Jiang, Junhong, et al.
Publicado: (2021)

Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
por: Kumar, Suresh, et al.
Publicado: (2019)

Rotational stability of the AcrySof SA60TT toric intraocular lenses: A cohort study
por: Zuberbuhler, Bruno, et al.
Publicado: (2008)

Long-Term Efficacy and Rotational Stability of AcrySof Toric Intraocular Lens Implantation in Cataract Surgery
por: Kim, Myung Hun, et al.
Publicado: (2010)

Management of moderate and severe corneal astigmatism with AcrySof® toric intraocular lens implantation – Our experience
por: Farooqui, Javed Hussain, et al.
Publicado: (2015)

Factors affecting eye drop instillation in glaucoma patients with visual field defect
por: Naito, Tomoko, et al.
Publicado: (2017)

Common Variants on Chromosome 9p21 Are Associated with Normal Tension Glaucoma
por: Takamoto, Mitsuko, et al.
Publicado: (2012)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Lafuma, Antoine, et al.
Publicado: (2011)

Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
por: Naito, Tomoko, et al.
Publicado: (2016)

The effects of selective laser trabeculoplasty and travoprost on circadian intraocular pressure fluctuations: A randomized clinical trial
por: Kiddee, Weerawat, et al.
Publicado: (2017)

Optical bench performance of AcrySof(®) IQ ReSTOR(®), AT LISA(®) tri, and FineVision(®) intraocular lenses
por: Carson, Daniel, et al.
Publicado: (2014)

Visian implantable contact lens versus AcrySof Cachet phakic intraocular lenses: comparison of aberrmetric profiles
por: Hosny, Mohamed HM, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9ef36nr225n41lnfdp3n2l57u4